Company Information
CIN
Status
Date of Incorporation
23 July 1984
State / ROC
/ ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
Paid Up Capital
100,277,506
Authorised Capital
857,500,000
Directors
Bal Ram Singh
Director/Designated Partner
about 2 years ago
about 2 years ago
Pranav Jayesh Choksi
Director/Designated Partner
about 2 years ago
about 2 years ago
Rabi Narayan Sahoo
Director/Designated Partner
over 2 years ago
over 2 years ago
Jayesh Pannalal Choksi
Director/Designated Partner
over 2 years ago
over 2 years ago
Shreyas Kantilal Patel
Director/Designated Partner
over 2 years ago
over 2 years ago
Pankaj Jayakumar Gandhi
Director/Designated Partner
almost 3 years ago
almost 3 years ago
Dilip Ghosh
Director/Designated Partner
about 4 years ago
about 4 years ago
Anu Sanjiv Aurora
Director/Designated Partner
about 5 years ago
about 5 years ago
Shrirang Vishwanath Vaidya
Director/Designated Partner
about 7 years ago
about 7 years ago
Gopal Madhavbhai Daptari
Director/Designated Partner
over 8 years ago
over 8 years ago
Past Directors
Hemal Milan Desai
Additional Director
about 11 years ago
about 11 years ago
Jagdish Dwarkadas Shah
Director
about 12 years ago
about 12 years ago
Ashok Mashnu Tarale
Director
almost 23 years ago
almost 23 years ago
Sharat Shantilal Gandhi
Director
over 23 years ago
over 23 years ago
Patents
“A Freeze Dried Parenteral Composition of Tigecycline and Process for Preparation Thereof”
A stable, freeze dried pharmaceutical composition comprising Tigecycline along with sulfobutyl ether betacyclodextrin sodium as stabilizing agent for parenteral administration. The pharmaceutical composition provides sta...
Discloses a process for extraction of Withanoside IV and Withanoside V from Ashwagandha (Withania somnifera) roots and a pharmaceutical composition containing the Withanosides IV and V along with pharmaceutically acceptable excipients, for the treatment of relieving anxiety and stress.
The present invention discloses an alcohol and acid free stable pharmaceutical composition for parenteral administration, which comprises,
a) Levosimendan or a pharmaceutically acceptable salt thereof at least in an amount of 1 to 25mg/vial;
b) an effective amount of polyvinyl pyrrolidone in aqueous vehicle as a s...
The present invention discloses a freeze dried, micelle-forming surfactant free pharmaceutical formulation of anidulafungin along with a suitable solubilizing agent and acidifying agent for parenteral administration. The pharmaceutical formulation provides sufficient solubilization and stabilization of anidulafun...
The present invention discloses stable freeze dried pharmaceutical formulations of Micafungin which comprises Micafungin sodium; a suitable stabilizing agent and alkalizing agent, for parenteral administration, wherein, the formulation is devoid of polysaccharide and disaccharide. The pharmaceutical formulation prov...
A lyophilized pharmaceutical composition comprising: a) dalbavancin hydrochloride or its pharmaceutically acceptable salt; b) a pharmaceutically acceptable amount of amino acid as stabilizer) the ratio of dalvabancin to stabilizer is 1:0.8 to 1:1 by weight, d) said formulation has a pH in the range of 5.1-6 v) s...
The present invention discloses an alcohol and acid free pharmaceutical composition for parental administration comprising; (i) levosimendan or a pharmaceutically acceptable salt thereof as an active ingredient; (ii) 10% solution of Kollidone PF-12 in aqueous solution as a solubilizing agent; and (iii) pharmaceutica...
The present invention discloses herein a freeze dried pharmaceutical formulation of Rifabutin along with a suitable solubilizing agent and Bulking agent for parenteral administration which provides sufficient solubilization and stabilization of Rifabutin thus improving the shelf life and reduces the likelihood of pr...
The present invention discloses stable aqueous, pharmaceutical composition of Cetrorelix acetate along with a suitable stabilizing agent and tonicity adjusting agent (s) for parenteral administration. The pharmaceutical composition provides sufficient stabilization of Cetrorelix acetate thus improving the shelf life...
Disclosed herein is a stable, freeze dried pharmaceutical composition, free of Sucrose comprising Omadacycline Tosylate along with a suitable stabilizing agent for parenteral administration. The pharmaceutical composition provides a process for stabilization of Omadacycline Tosylate thereby improving the shelf life ...
Disclosed herein is a freeze dried pharmaceutical composition for parenteral administration with improved stability and reduced impurities, comprising Omadacycline Tosylate with sodium bisulfite and arginine as stabilizing agents. The invention further discloses a process for preparation of said composition.
...
A Freeze Dried Parenteral Composition Of Isavuconazonium Sulfate And Process For Preparation Thereof
Disclosed herein is a stable, freeze dried pharmaceutical composition comprising Isavuconazonium Sulfate along with a suitable stabilizing agents for parenteral administration. The pharmaceutical composition provides stabilization of Isavuconazonium Sulfate and prevents the formation of visible particulates after re...
The present disclosure relates to the use of thymosin alpha-1 for the treatment of endometriosis and symptoms thereof in a subject. The present disclosure also provides a pharmaceutical composition for use in the treatment of endometriosis, which comprises therapeutic amounts of thymosin alpha-1 and a pharmaceutical...
The present invention relates to a pregnancy stretch mark assessment device and method to enable healthcare professionals and individuals to make informed decisions regarding proactive management and prevention strategies on stretch mark. Accordingly, a pregnancy stretch mark assessment device (10) to assess the ris...
Registered Trademarks
[Class : 5] Pharmaceutical And Medical Preparation
[Class : 5] Pharmaceutical And Medical Preparation
[Class : 5] Pharmaceutical And Medical Preparation
View +428 more Brands for Gufic Biosciences Limited.
Charges
21 August 2023
Others
0
08 December 2022
Hdfc Bank Limited
0
27 December 2022
Others
0
21 September 2022
Others
0
07 March 2017
Hdfc Bank Limited
0
30 November 2017
Others
0
17 February 2018
Others
0
17 February 2018
Others
0
29 May 2018
Others
0
01 June 2018
Others
0
06 July 2018
Others
0
07 March 2017
Hdfc Bank Limited
0
29 March 2017
Others
0
03 January 2017
Others
0
21 June 2016
Others
0
12 March 2005
Dena Bank
0
14 June 2005
State Bank Of India
0
06 October 2004
Dena Bank
0
11 May 2004
The Saraswat Co-op. Bank Ltd.
0
08 January 2004
Uti Bank Ltd.
0
07 April 2003
The Saraswat Co-op. Bank Ltd.
0
28 March 2003
The Saraswat Co-op. Bank Ltd.
0
27 February 2003
The Saraswat Co-op. Bank Ltd.
0
02 February 2003
The Saraswat Co-op. Bank Ltd.
0
13 September 1995
Bank Of Punjab Ltd.
0
11 March 1995
Corporation Bank
0
02 February 1985
The Memon Co-op.; Bank Ltd.
0
12 March 2005
Dena Bank
0
12 August 2014
The Saraswat Cooperative Bank Ltd
0
21 June 2012
Intec Capital Limited
0
21 December 2012
The Saraswat Cooperative Bank Ltd
0
31 December 2012
The Saraswat Cooperative Bank Ltd
0
05 January 2013
The Saraswat Cooperative Bank Ltd
0
31 March 2022
Others
0
14 February 2022
Others
0
25 January 2022
Axis Bank Limited
0
25 October 2021
Others
0
21 December 2012
Others
0
25 October 2021
Others
0
04 January 2013
Others
0
13 January 2020
Others
0
16 March 2020
Axis Bank Limited
0
11 March 2019
Others
0
05 May 2020
Others
0
14 June 2013
Others
0
31 July 2019
Others
0
04 June 2014
The Saraswat Co-op Bank Ltd
0
